药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Temafloxacin
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Temafloxacin.
Sulfacytine
Nicorandil
Nicorandil may increase the hypotensive activities of Canagliflozin.
Sulfacytine
Aripiprazole lauroxil
Aripiprazole lauroxil may increase the hypotensive activities of Canagliflozin.
Sulfacytine
Fosphenytoin
The serum concentration of Canagliflozin can be decreased when it is combined with Fosphenytoin.
Sulfacytine
Azosemide
The risk or severity of hypotension can be increased when Canagliflozin is combined with Azosemide.
Sulfacytine
Piretanide
The risk or severity of hypotension can be increased when Canagliflozin is combined with Piretanide.
Sulfacytine
Cilazaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Cilazaprilat.
Sulfacytine
Quinaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Quinaprilat.
Sulfacytine
Perindoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Perindoprilat.
Sulfacytine
Ramiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Ramiprilat.
Sulfacytine
Fosinoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Fosinoprilat.
Sulfacytine
Benazeprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Benazeprilat.
Sulfacytine
Delapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Delapril.
Sulfacytine
Zofenopril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Zofenopril.
Sulfacytine
Imidapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Imidapril.
Sulfacytine
Enalaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Enalaprilat.
Sulfacytine
Quinoline Yellow WS
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Quinoline Yellow WS.
Sulfacytine
Moexiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Moexiprilat.
Sulfacytine
Trandolaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Canagliflozin is combined with Trandolaprilat.
Sulfacytine
Candesartan
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Candesartan.